We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.72B
AUM Growth
+$377M
Cap. Flow
-$47.5M
Cap. Flow %
-0.83%
Top 10 Hldgs %
18.31%
Holding
1,615
New
130
Increased
604
Reduced
665
Closed
130

Sector Composition

Rank Sector Weight
1 Technology 19.17%
2 Financials 10.88%
3 Healthcare 10.31%
4 Consumer Discretionary 9.37%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KIO
1401
KKR Income Opportunities Fund
KIO
$454M
$195K ﹤0.01%
11,550
-2,500
-18% -$41K
ACHV icon
1402
Achieve Life Sciences
ACHV
$647M
$193K ﹤0.01%
24,800
-200
-0.8% -$1.57K
OGCP
1403
Empire State Realty Series 60
OGCP
$1.26B
$191K ﹤0.01%
+21,474
New +$207K
EMD
1404
Western Asset Emerging Markets Debt Fund
EMD
$611M
$182K ﹤0.01%
+14,231
New +$189K
IVH
1405
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
$182K ﹤0.01%
13,100
-3,000
-19% -$41.8K
ALLO icon
1406
Allogene Therapeutics
ALLO
$680M
$180K ﹤0.01%
12,050
-1,095
-8% -$19.3K
RKT icon
1407
Rocket Companies
RKT
$37.5B
$179K ﹤0.01%
12,782
-21,282
-62% -$339K
CRNT icon
1408
Ceragon Networks
CRNT
$197M
$177K ﹤0.01%
68,500
+10,000
+17% +$30.1K
NID
1409
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
$177K ﹤0.01%
+11,831
New +$176K
SIRI icon
1410
SiriusXM
SIRI
$10.4B
$175K ﹤0.01%
2,758
VBIV
1411
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$170K ﹤0.01%
2,417
+53
+2% +$4.47K
TVRD
1412
Tvardi Therapeutics
TVRD
$19.7M
$165K ﹤0.01%
377
-152
-29% -$76.4K
HIO
1413
Western Asset High Income Opportunity Fund
HIO
$334M
$164K ﹤0.01%
31,530
-610
-2% -$3.15K
HUGS
1414
DELISTED
USHG Acquisition Corp.
HUGS
$164K ﹤0.01%
+15,800
New +$160K
CHW
1415
Calamos Global Dynamic Income Fund
CHW
$523M
$162K ﹤0.01%
16,251
-1,443
-8% -$14.6K
BLDP
1416
Ballard Power Systems
BLDP
$841M
$161K ﹤0.01%
12,790
-2,600
-17% -$39.3K
WIW
1417
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$507M
$160K ﹤0.01%
11,800
NNY icon
1418
Nuveen New York Municipal Value Fund
NNY
$156M
$158K ﹤0.01%
16,000
-1,000
-6% -$9.94K
SANA icon
1419
Sana Biotechnology
SANA
$904M
$158K ﹤0.01%
10,200
-17,950
-64% -$346K
ENLC
1420
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$158K ﹤0.01%
22,895
AMPS
1421
DELISTED
Altus Power
AMPS
$157K ﹤0.01%
+15,000
New +$152K
CFB
1422
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$156K ﹤0.01%
10,000
-14,000
-58% -$204K
EIM
1423
Eaton Vance Municipal Bond Fund
EIM
$494M
$155K ﹤0.01%
+11,425
New +$153K
FEI
1424
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
$155K ﹤0.01%
21,339
BOE icon
1425
BlackRock Enhanced Global Dividend Trust
BOE
$675M
$154K ﹤0.01%
12,629
+98
+0.8% +$1.18K

Similar funds

Oppenheimer & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Oppenheimer & Co held 1,615 positions worth $5.72B, up 7.1% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q4 2021 filing shows 130 new, 604 increased, 665 reduced and 130 closed positions. Its largest new stake was Invesco Total Return Bond ETF: 132,838 shares worth $7.49M. The largest sale was Global X S&P 500 Covered Call ETF, an estimated $49.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q4 2021 buy was Invesco Total Return Bond ETF: 132,838 shares worth $7.49M.
  • Oppenheimer & Co added most to Canadian Pacific Kansas City in Q4 2021, an estimated $7.48M increase.
  • Oppenheimer & Co's biggest Q4 2021 reduction was Global X S&P 500 Covered Call ETF, cutting an estimated $49.9M.
  • Oppenheimer & Co fully exited Kansas City Southern in Q4 2021, selling an estimated $6.61M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.72B portfolio in Q4 2021.
  • Oppenheimer & Co opened 130 new positions and closed 130 in Q4 2021.
  • Oppenheimer & Co's portfolio value rose 7.1% quarter-over-quarter to $5.72B.

Based on Oppenheimer & Co's 13F filing for Q4 2021, filed 2 Feb 2022.